Ironwood Pharmaceuticals Inc. Class A (IRWD) Key Ratios
$4.73
As on 20-Nov-2026 12:37EST
Market cap
$800 Mln
Revenue (TTM)
$400 Mln
P/E Ratio
5.4
P/B Ratio
2.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 17.69 | 9.00 | 18.09 | -2.54 | -0.64 |
| EBIT | 15.89 | 22.68 | 77.51 | 2.50 | 2.39 |
| Net Profit | 16.66 | 49.30 | 424.10 | 29.31 | -22.00 |
| EPS | 16.28 | 59.88 | 488.94 | 28.96 | -22.58 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 35.39 | 45.12 | 64.30 | 34.70 | 27.24 |
| Net Margin
| -- | 84.76 | 37.38 | -- | -- |
| Return on equity
| -221.23 | -95.55 | -- | -8.53 | -0.27 |
| Return on Capital
| -43.87 | -9.84 | -- | 7.57 | 0.26 |
| Return on Assets
| -40.30 | -8.50 | 31.05 | 6.42 | 0.21 |
| Debt to Equity (x)
| -- | -- | -3.34 | -2.28 | -1.99 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
7.57
|
0.26
|
-139.44
|
16.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
-8.53
|
-0.27
|
-654.88
|
27.83
|
|
Peer Median
|
-39.52
|
--
|
--
|
--
|
--
|
ROA
31.05
Higher than Peers by 62.19
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
31.05
|
6.42
|
0.21
|
-127.54
|
15.72
|
|
Peer Median
|
-31.14
|
--
|
--
|
--
|
--
|
EBIT Margin
64.30
Higher than Peers by 124.32
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
64.30
|
34.70
|
27.24
|
44.23
|
63.33
|
|
Peer Median
|
-60.02
|
--
|
--
|
--
|
--
|
Net Margin
37.38
Higher than Peers by 106.25
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
37.38
|
8.11
|
0.25
|
-226.37
|
41.65
|
|
Peer Median
|
-68.87
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
18.09
Lower than Peers by 36.91
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
18.09
|
-0.16
|
-0.21
|
0.08
|
-0.01
|
|
Peer Median
|
55.00
|
--
|
--
|
--
|
--
|
EBIT Growth
77.51
Higher than Peers by 78.99
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
77.51
|
7.37
|
-51.12
|
-24.68
|
11.97
|
|
Peer Median
|
-1.47
|
--
|
--
|
--
|
--
|
Net Profit Growth
424.10
Higher than Peers by 430.15
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
424.10
|
2,629.20
|
100.09
|
-672.50
|
-66.87
|
|
Peer Median
|
-6.05
|
--
|
--
|
--
|
--
|
EPS Growth
488.94
Higher than Peers by 475.58
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
488.94
|
23.63
|
1.00
|
-7.80
|
-0.70
|
|
Peer Median
|
13.36
|
--
|
--
|
--
|
--
|
Book Value Growth
60.60
Higher than Peers by 68.80
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
60.60
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-8.20
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-3.34
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
-3.34
|
-2.28
|
-1.99
|
-2.07
|
0.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.03
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
-0.03
|
-0.78
|
-0.01
|
-0.59
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.51
Higher than Peers by 0.71
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
6.51
|
1.13
|
4.69
|
0.84
|
30.58
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
6.51
Higher than Peers by 0.85
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
6.51
|
--
|
--
|
0.84
|
30.53
|
|
Peer Median
|
5.65
|
--
|
--
|
--
|
--
|
Interest Coverage
8.46
Higher than Peers by 10.55
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
8.46
|
3.14
|
2.90
|
9.05
|
34.22
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
33.16
Higher than Peers by 14.28
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
33.16
|
15.78
|
23.30
|
29.16
|
28.12
|
|
Peer Median
|
18.87
|
--
|
--
|
--
|
--
|
Asset Turnover
0.83
Higher than Peers by 0.76
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
0.83
|
0.79
|
0.86
|
0.56
|
0.37
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
79.32
|
109.66
|
100.89
|
102.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
--
|
0.00
|
37.13
|
321.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
487.87
|
240.78
|
246.94
|
182.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
--
|
-131.12
|
-108.92
|
241.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
5.43
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
5.43
|
24.94
|
807.56
|
-1.78
|
13.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
2.59
Lower than Peers by 1.72
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
2.59
|
-2.29
|
-2.36
|
-5.15
|
3.52
|
|
Peer Median
|
4.31
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
4.06
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
4.06
|
9.38
|
12.50
|
12.20
|
7.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
800
Higher than Peers by 661
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Ironwood Pharmaceuticals Inc. Class A (IRWD)
|
800
|
--
|
--
|
--
|
--
|
|
Peer Median
|
138
|
--
|
--
|
--
|
--
|